The most common adverse reactions (incidence of ≥ 25%) in patients treated with Ceritinib 450 mg with food are diarrhea, nausea, abdominal pain, vomiting, and fatigue; and with Ceritinib 750 mg under fasted conditions are diarrhea, nausea, vomiting, fatigue, abdominal pain, decreased appetite, and weight loss.
from FDA,2021.10